​

Processa Pharmaceuticals (PCSA) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Processa Pharmaceuticals Revenue Highlights

00

Processa Pharmaceuticals Revenue by Period

Processa Pharmaceuticals Revenue by Year

DateRevenueChange
2024-12-31-100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31--100.00%
2016-12-31$5.00K-95.59%
2015-12-31$113.42K-43.34%
2014-12-31$200.20K-35.93%
2013-12-31$312.48K62.63%
2012-12-31$192.15K860.73%
2011-12-31$20.00K-85.71%
2010-12-31$140.00K-

Processa Pharmaceuticals generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Processa Pharmaceuticals Revenue by Quarter

DateRevenueChange
2025-06-30-100.00%
2025-03-31--100.00%
2024-12-31$12.47M100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31-100.00%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31--100.00%
2021-12-31$175.40K100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31--100.00%
2020-12-31$-277.95K100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30--100.00%
2016-03-31$5.00K-143.98%
2015-12-31$-11.37K-119.55%
2015-09-30$58.16K190.24%
2015-06-30$20.04K-56.99%
2015-03-31$46.59K223.54%
2014-12-31$14.40K-72.63%
2014-09-30$52.62K-53.36%
2014-06-30$112.83K454.61%
2014-03-31$20.34K-70.97%
2013-12-31$70.09K-44.33%
2013-09-30$125.91K29.43%
2013-06-30$97.28K406.67%
2013-03-31$19.20K-38.95%
2012-12-31$31.45K-35.89%
2012-09-30$49.06K-49.44%
2012-06-30$97.02K563.90%
2012-03-31$14.61K46.14%
2011-12-31$10.00K-

Processa Pharmaceuticals generated - in revenue during Q2 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Processa Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
CRISCuris$10.91M$2.75M
CTXRCitius Pharmaceuticals--
BCTXBriaCell Therapeutics--
ALLRAllarity Therapeutics--
MBRXMoleculin Biotech--
LPTXLeap Therapeutics--
ATHAAthira Pharma--
PALIPalisade Bio--
PCSAProcessa Pharmaceuticals--
HOTHHoth Therapeutics--

PCSA Revenue FAQ

What is Processa Pharmaceuticals’s yearly revenue?

Processa Pharmaceuticals's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. PCSA's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Processa Pharmaceuticals’s quarterly revenue?

Processa Pharmaceuticals's quarterly revenue for Q2 2025 was $0, a 100.00% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024). PCSA's quarterly revenue for Q4 2024 was $12.47M, a 100.00% increase from the previous quarter (Q3 2024), and a 0% increase year-over-year (Q4 2023).

What is Processa Pharmaceuticals’s revenue growth rate?

Processa Pharmaceuticals's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.